
    
      This is an observational, prospective, multicenter study of newly transplanted adult, first
      lung transplant recipients that will collect longitudinal clinical data, patient reported
      quality of life (QOL) data, and serial biological samples to determine the risk factors,
      pathophysiology, and manifestations of restrictive chronic lung allograft dysfunction (RCLAD)
      and bronchiolitis obliterans syndrome (BOS). Anticipated participant accrual is within three
      years of study start-up. The total study duration is four years. Participants will be
      followed a minimum of 1 and a maximum of 4 years.
    
  